Suppr超能文献

抑制多种 DsbA 酶在多 DsbA 编码病原体中的作用。

Inhibition of Diverse DsbA Enzymes in Multi-DsbA Encoding Pathogens.

机构信息

1 Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology , Queensland, Australia .

2 Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University , Bundoora, Australia .

出版信息

Antioxid Redox Signal. 2018 Sep 1;29(7):653-666. doi: 10.1089/ars.2017.7104. Epub 2018 Feb 1.

Abstract

AIMS

DsbA catalyzes disulfide bond formation in secreted and outer membrane proteins in bacteria. In pathogens, DsbA is a major facilitator of virulence constituting a target for antivirulence antimicrobial development. However, many pathogens encode multiple and diverse DsbA enzymes for virulence factor folding during infection. The aim of this study was to determine whether our recently identified inhibitors of Escherichia coli K-12 DsbA can inhibit the diverse DsbA enzymes found in two important human pathogens and attenuate their virulence.

RESULTS

DsbA inhibitors from two chemical classes (phenylthiophene and phenoxyphenyl derivatives) inhibited the virulence of uropathogenic E. coli and Salmonella enterica serovar Typhimurium, encoding two and three diverse DsbA homologues, respectively. Inhibitors blocked the virulence of dsbA null mutants complemented with structurally diverse DsbL and SrgA, suggesting that they were not selective for prototypical DsbA. Structural characterization of DsbA-inhibitor complexes showed that compounds from each class bind in a similar region of the hydrophobic groove adjacent to the Cys30-Pro31-His32-Cys33 (CPHC) active site. Modeling of DsbL- and SrgA-inhibitor interactions showed that these accessory enzymes could accommodate the inhibitors in their different hydrophobic grooves, supporting our in vivo findings. Further, we identified highly conserved residues surrounding the active site for 20 diverse bacterial DsbA enzymes, which could be exploited in developing inhibitors with a broad spectrum of activity. Innovation and Conclusion: We have developed tools to analyze the specificity of DsbA inhibitors in bacterial pathogens encoding multiple DsbA enzymes. This work demonstrates that DsbA inhibitors can be developed to target diverse homologues found in bacteria. Antioxid. Redox Signal. 29, 653-666.

摘要

目的

DsbA 在细菌的分泌蛋白和外膜蛋白中催化二硫键的形成。在病原体中,DsbA 是毒力的主要促进剂,构成抗毒力抗菌药物开发的靶点。然而,许多病原体在感染过程中编码多种和多样化的 DsbA 酶来折叠毒力因子。本研究旨在确定我们最近鉴定的大肠杆菌 K-12 DsbA 的抑制剂是否可以抑制两种重要人类病原体中发现的多样化 DsbA 酶,并减弱它们的毒力。

结果

两种化学类别的 DsbA 抑制剂(苯并噻吩和苯氧苯基衍生物)抑制了编码两种和三种不同 DsbA 同源物的尿路致病性大肠杆菌和肠炎沙门氏菌血清型 Typhimurium 的毒力。抑制剂阻断了结构不同的 DsbL 和 SrgA 互补的 dsbA 缺失突变体的毒力,表明它们不是对典型 DsbA 的选择性。DsbA-抑制剂复合物的结构特征表明,每个类别的化合物都结合在邻近 Cys30-Pro31-His32-Cys33(CPHC)活性位点的疏水性凹槽的相似区域。DsbL 和 SrgA-抑制剂相互作用的建模表明,这些辅助酶可以在它们不同的疏水性凹槽中容纳抑制剂,支持我们的体内发现。此外,我们鉴定了 20 种不同细菌 DsbA 酶周围的活性位点周围高度保守的残基,这些残基可以用于开发具有广泛活性的抑制剂。

创新和结论

我们已经开发了用于分析编码多种 DsbA 酶的细菌病原体中 DsbA 抑制剂特异性的工具。这项工作表明,DsbA 抑制剂可以被开发用于靶向细菌中发现的多样化同源物。抗氧化剂。氧化还原信号。29,653-666。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5cd/6067686/71aeff8888a6/fig-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验